bluebird bio Inc (BLUE)
0.8998
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.904
0.00 (0.00%)
After-Hours: 20:00
bluebird bio Free Cash Flow: -286.43M for Sept. 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2023 | -286.43M |
| June 30, 2023 | -300.84M |
| March 31, 2023 | -327.75M |
| December 31, 2022 | -366.16M |
| September 30, 2022 | -446.56M |
| June 30, 2022 | -524.95M |
| March 31, 2022 | -573.84M |
| December 31, 2021 | -658.64M |
| September 30, 2021 | -679.94M |
| June 30, 2021 | -677.66M |
| March 31, 2021 | -493.49M |
| December 31, 2020 | -499.34M |
| September 30, 2020 | -508.62M |
| June 30, 2020 | -492.54M |
| March 31, 2020 | -683.96M |
| December 31, 2019 | -640.64M |
| September 30, 2019 | -610.89M |
| June 30, 2019 | -569.20M |
| March 31, 2019 | -526.36M |
| December 31, 2018 | -469.16M |
| September 30, 2018 | -440.75M |
| June 30, 2018 | -404.36M |
| Date | Value |
|---|---|
| March 31, 2018 | -357.74M |
| December 31, 2017 | -342.80M |
| September 30, 2017 | -310.71M |
| June 30, 2017 | -298.86M |
| March 31, 2017 | -278.34M |
| December 31, 2016 | -217.68M |
| September 30, 2016 | -172.07M |
| June 30, 2016 | -153.80M |
| March 31, 2016 | -120.83M |
| December 31, 2015 | -105.48M |
| September 30, 2015 | -87.03M |
| June 30, 2015 | -79.45M |
| March 31, 2015 | -79.26M |
| December 31, 2014 | -68.40M |
| September 30, 2014 | -61.08M |
| June 30, 2014 | -49.51M |
| March 31, 2014 | -44.88M |
| December 31, 2013 | 34.78M |
| September 30, 2013 | 38.53M |
| June 30, 2013 | 45.24M |
| March 31, 2013 | 49.79M |
| December 31, 2012 | -21.91M |
Free Cash Flow Range, Past 5 Years
-683.96M
Minimum
Mar 2020
-286.43M
Maximum
Sep 2023
-518.97M
Average
-516.79M
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | 3.279B |
| Novavax Inc | -772.77M |
| Motus GI Holdings Inc | -11.30M |
| Tivic Health Systems Inc | -8.629M |
| AIM ImmunoTech Inc | -21.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -61.85M |
| Cash from Investing (Quarterly) | 62.08M |
| Cash from Financing (Quarterly) | -0.042M |
| Free Cash Flow Per Share (Quarterly) | -0.5856 |
| Free Cash Flow to Equity (Quarterly) | -63.88M |
| Free Cash Flow to Firm (Quarterly) | -63.88M |
| Free Cash Flow Yield | -313.4% |